Literature DB >> 11125300

Caspase inhibition reveals functional cooperation between p55- and p75-TNF receptors in cell necrosis.

M Pelagi1, F Curnis, B Colombo, P Rovere, A Sacchi, A A Manfredi, A Corti.   

Abstract

TNF-induced caspase activation is critically involved in both apoptosis and protection from cell necrosis. We have investigated the roles of the p55- and p75-TNF receptors (TNFR1 and TNFR2) in the induction of mouse L-M cell death in the presence of a caspase inhibitor (zVAD-fmk) and a transcription inhibitor (actinomycin D), i.e. under conditions in which protective pathways requiring caspase activation and protein synthesis were blocked. Cytometric analysis after TNF treatment showed that apoptosis was inhibited, while necrosis was highly activated. In contrast, apoptosis was observed in cells treated with TNF and actinomycin D alone. Stimulation of TNFR1 was sufficient to induce either cell necrosis or apoptosis, even when we blocked endogenous TNF with an anti-murine TNF antibody. Experiments based on the use of receptor-agonist and antagonist antibodies also showed that TNFR2 contributes to cell necrosis and apoptosis. Simultaneous stimulation of TNFR2 and TNFR1 with specific agonists indicated that TNFR2 functionally cooperates with TNFR1 to potentiate the response indirectly, by inducing endogenous TNF cytotoxicity. Caspase inhibitors enhanced the cytotoxic effect of endogenous TNF, suggesting that TNFR2 modulation can regulate the global necrotic response to TNF. TNFR2 modulation could play an important role in determining the response to TNF in pathophysiological conditions characterized by caspase down-regulation and local TNF production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11125300

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  6 in total

1.  Chitosan-modified cobalt oxide nanoparticles stimulate TNF-α-mediated apoptosis in human leukemic cells.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Santanu Kar Mahapatra; Satyajit Tripathy; Totan Ghosh; Balaram Das; Debasis Das; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2014-01-21       Impact factor: 3.358

2.  Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-26       Impact factor: 4.030

3.  Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration.

Authors:  Flavio Curnis; Angelina Sacchi; Angelo Corti
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 4.  Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.

Authors:  Angelo Corti; Flavio Curnis; Gilda Rossoni; Fabrizio Marcucci; Vanesa Gregorc
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

5.  Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis.

Authors:  Daniela Siegmund; Juliane Kums; Martin Ehrenschwender; Harald Wajant
Journal:  Cell Death Dis       Date:  2016-09-22       Impact factor: 8.469

Review 6.  Tumor necrosis factor-alpha in normal and diseased brain: Conflicting effects via intraneuronal receptor crosstalk?

Authors:  Seth W Perry; Stephen Dewhurst; Matthew J Bellizzi; Harris A Gelbard
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.